期刊文献+

载siRNA阳离子脂质体的制备 被引量:7

Preparation and characterization of cationic liposomes entrapping siRNA
下载PDF
导出
摘要 目的制备载siRNA阳离子脂质体并对其进行制剂学评价。方法利用siRNA与溴化乙锭结合能产生荧光的原理,采用预染溴化乙锭(Ethidium Bromide,EB)琼脂糖凝胶,氨基丁三醇-硼酸-乙二胺四乙酸(Tris-Boric acid-EDTA,TBE)电泳缓冲液将游离siRNA分离并通过凝胶成像分析系统转换数据进行定性和定量,计算载siRNA阳离子脂质体包封率,并考察其阴离子的抵御能力和血清稳定性;利用Malver粒径和zeta电位测定仪对不同载siRNA阳离子脂质体进行评价。结果琼脂糖凝胶电泳法的线性为0.665~13.30 mg·L-1(R2=0.988 3),回收率为97%-103%,精密度RSD〈2%,阳离子脂质体对siRNA包封率较高,且具有良好的抵御阴离子能力和较强的血清稳定性;载siRNA阳离子脂质体的粒径和zeta电位变化与文献报道一致。结论所制备的载siRNA阳离子脂质体体外性质均良好。 Objective To prepare and characterize cationic liposomes entrapping siRNA. Methods Agarose electrophoresis in TBE solution could be used to separate free siRNA from liposome,which and fluorescence emission after siRNA binding to EB could be applied to test siRNA stability against polyanion and in serum,and determine the encapsulation efficiency of siRNA loaded in cationic liposome; The sizes and zeta potentional of both liposome and lipoplexes were determined by Malvern apparatus. Results The determination method was linear in 0. 665- 13. 30 mg·L- 1with correlation coefficients of 0. 988 3. The recovery was at 97%-103%,and the RSDs were within 2%; It was as literature reported that the sizes and zeta potentional of lipoplexes were different at various weight ratios. Conclusions The entrapment efficiency of lipoplexes is over 80%; and the lipoplexes perform good in stability in serum and resistance against polyanion.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2015年第7期510-514,518,共6页 Journal of Shenyang Pharmaceutical University
基金 2014辽宁省大学生创新创业训练计划 国家自然科学基金资助项目(81202483)
关键词 SIRNA 琼脂糖凝胶电泳 包封率 阳离子脂质体 血清稳定性 阴离子抵御 siRNA agarose gel electrophoresis encapsulation efficiency cationic liposome stability in serum polyanion displacement
  • 相关文献

参考文献9

  • 1RANJITA M,MANASI D,BHABANI S,et al. Rever- sal of multidrug resistance in vitro by co-delivery of MDR1 targeting siRNA and doxorubicin using a novel cationic poly ( lactide-co-glycolide ) nanoformulation [ J]. International Journal of Pharmaceutics ,2014,475 (1/2) :372 -384.
  • 2WANG Zhi-yong, LIU Gang, ZHENG Hai-rong, et al. Rigid nanoparticle-based delivery of anti-cancer siR- NA: challenges and opportunities [ J 1- Biotechnol Adv,2014,32 ( 4 ) : 831 - 843.
  • 3OS6 M B, SHINJI K, TATSUAKI T, et al. Agitation during lipoplex formation harmonizes the interaction of siRNA to cationic liposomes [ J 1. Int J Pharm, 2012,430 (1/2) :359 - 365.
  • 4QI Ruo-gu, LIU Shi, CHEN Jie, et al. Biodegradable copolymers with identical cationic segments and theirperformance in siRNA delivery [ J ]. Journal of Con- trolled Release, 2012,159 (2) :251 - 260.
  • 5NIRAV K, DIPESH B, IMRAN V, et al. Development and characterization of siRNA lipoplexes: effect of dif- ferent lipids,in vitro evaluation in cancerous cell lines and in vivo toxicity study [ J ]. AAPS PharmSciTech, 2014,15:1630 - 1643.
  • 6WANG Ming-yue,HU Hai-yang, SUN Yu-qi, et al. A pH-sensitive gene delivery system based on folic acid- PEG-chitosan-PAMAM-plasmid DNA complexes for cancer cell targeting[ J]. Biomaterials ,2013,34 ( 38 ) : 10120 - 10132.
  • 7沈雁,涂家生,庞卉,朱家壁.凝胶电泳法及荧光光度法测定siRNA阳离子脂质体的含量和包封率[J].药学学报,2009,44(4):430-435. 被引量:10
  • 8LI Yan, CHENG Qiang, JIANG Qian, et al. Enhanced endosomal/lysosomal escape by distearoyl-phospho- ethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA[ J ]. Journal of Controlled Release, 2014,176 : 104 - 114.
  • 9NISHANT S G, RAKESH K T, MAHAVIR B C. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances [ J 1. Journal of Controlled Release,2014,194:238 - 256.

二级参考文献4

共引文献9

同被引文献51

引证文献7

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部